Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Zimmer

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|November 4, 2008
NK cells and Treg cells: a fascinating dance cheek to cheekJacques Zimmer, Emmanuel Andrès, François Hentges
Frontiers in Immunology|December 6, 2021
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated TherapiesJacques Zimmer, Roberta Castriconi, Silvia Scaglione
Current Opinion in Immunology|March 14, 2003
The NK cell receptor repertoire: formation, adaptation and exploitationWerner Held, Jérôme D Coudert, Jacques Zimmer
Scandinavian Journal of Immunology|February 12, 2021
Human natural killer cells in major histocompatibility complex class I deficiencyNeha D Patil, Maud Theresine, Jacques Zimmer
Methods in Cell Biology|February 7, 2025
Flow cytometry conjugate formation assay between natural killer cells and their target cellsGilles Iserentant, Carole Seguin-Devaux, Jacques Zimmer
Cellular & Molecular Immunology|May 24, 2024
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseasesCamille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Frontiers in Immunology|October 26, 2020
Airway Natural Killer Cells and Bacteria in Health and DiseaseMaud Theresine, Neha D Patil, Jacques Zimmer
Trends in Immunology|March 3, 2018
Revisiting the Functional Impact of NK CellsAurélie Poli, Tatiana Michel, Neha Patil, et al.
Cells|April 8, 2020
Revisiting the Role of Neurotrophic Factors in InflammationLucas Morel, Olivia Domingues, Jacques Zimmer, et al.
Leukemia Research|October 9, 2007
Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: the tumour might strike back. Comment on "differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]Jacques Zimmer, Tatiana Michel, Emmanuel Andrès, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|November 4, 2008
NK cells and Treg cells: a fascinating dance cheek to cheekJacques Zimmer, Emmanuel Andrès, François Hentges
Frontiers in Immunology|December 6, 2021
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated TherapiesJacques Zimmer, Roberta Castriconi, Silvia Scaglione
Current Opinion in Immunology|March 14, 2003
The NK cell receptor repertoire: formation, adaptation and exploitationWerner Held, Jérôme D Coudert, Jacques Zimmer
Scandinavian Journal of Immunology|February 12, 2021
Human natural killer cells in major histocompatibility complex class I deficiencyNeha D Patil, Maud Theresine, Jacques Zimmer
Methods in Cell Biology|February 7, 2025
Flow cytometry conjugate formation assay between natural killer cells and their target cellsGilles Iserentant, Carole Seguin-Devaux, Jacques Zimmer
Cellular & Molecular Immunology|May 24, 2024
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseasesCamille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Frontiers in Immunology|October 26, 2020
Airway Natural Killer Cells and Bacteria in Health and DiseaseMaud Theresine, Neha D Patil, Jacques Zimmer
Trends in Immunology|March 3, 2018
Revisiting the Functional Impact of NK CellsAurélie Poli, Tatiana Michel, Neha Patil, et al.
Cells|April 8, 2020
Revisiting the Role of Neurotrophic Factors in InflammationLucas Morel, Olivia Domingues, Jacques Zimmer, et al.
Leukemia Research|October 9, 2007
Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: the tumour might strike back. Comment on "differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]Jacques Zimmer, Tatiana Michel, Emmanuel Andrès, et al.
Pageof 9